Cancer research, DNA methylation, Cancer, Prostate cancer and microRNA are his primary areas of study. His Cancer research research incorporates elements of Prostate, Pathology, Molecular biology, Tumor suppressor gene and Regulation of gene expression. His Prostate research is multidisciplinary, relying on both Epithelium and Endocrinology.
His DNA methylation research incorporates themes from Histone, Methylation and Epigenetics. His Prostate cancer research includes elements of Histone deacetylase and Bioinformatics. His microRNA study integrates concerns from other disciplines, such as Genistein, Survivin, Immunology, HOTAIR and Gene silencing.
The scientist’s investigation covers issues in Cancer research, Prostate cancer, Cancer, Internal medicine and microRNA. His Cancer research research is multidisciplinary, incorporating elements of Wnt signaling pathway, Cell growth, DNA methylation, Carcinogenesis and Metastasis. His study in Prostate cancer is interdisciplinary in nature, drawing from both Prostate and Immunology.
His studies deal with areas such as Molecular biology, Gene and Renal cell carcinoma, Pathology as well as Cancer. The study incorporates disciplines such as Endocrinology, Oncology and Haplotype in addition to Internal medicine. His studies in microRNA integrate themes in fields like Epithelial–mesenchymal transition, Downregulation and upregulation, Genistein, Bioinformatics and Regulation of gene expression.
Rajvir Dahiya mainly focuses on Cancer research, Prostate cancer, Cancer, microRNA and Metastasis. The Cancer research study combines topics in areas such as Epithelial–mesenchymal transition, Cell growth, Gene knockdown, Carcinogenesis and Cell cycle. His Carcinogenesis study incorporates themes from DNA methylation, Oncogene, CYP1B1, Pathology and PTEN.
His Prostate cancer research includes themes of Prostate and Oncology. His Cancer research integrates issues from PI3K/AKT/mTOR pathway, Disease and Pathogenesis. His microRNA research includes elements of Suppressor, Regulation of gene expression, Metastasis Suppressor Gene and Ectopic expression.
His scientific interests lie mostly in Cancer research, Prostate cancer, microRNA, Cancer and Metastasis. His Cancer research research is multidisciplinary, incorporating elements of Gene knockdown, Cell growth, DNA methylation, Carcinogenesis and In vivo. His Carcinogenesis study integrates concerns from other disciplines, such as PTEN and Pathology.
Rajvir Dahiya has researched Prostate cancer in several fields, including Reprogramming, Prostate and Ectopic expression. His microRNA study combines topics from a wide range of disciplines, such as Epithelial–mesenchymal transition, Regulation of gene expression and Angiogenesis. His biological study deals with issues like Gene silencing, which deal with fields such as LNCaP, DU145, Methylation, Cell biology and Catenin complex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MethPrimer: designing primers for methylation PCRs
Long-Cheng Li;Rajvir Dahiya.
Bioinformatics (2002)
MicroRNA-373 induces expression of genes with complementary promoter sequences
Robert F Place;Long-Cheng Li;Deepa Pookot;Emily J Noonan.
Proceedings of the National Academy of Sciences of the United States of America (2008)
Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues
Samuel B. Ho;Gloria A. Niehans;Carolyn Lyftogt;Pei Sha Yan.
Cancer Research (1993)
Small dsRNAs induce transcriptional activation in human cells
Long-Cheng Li;Steven T. Okino;Hong Zhao;Deepa Pookot.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Hormonal, cellular, and molecular control of prostatic development.
Paul C Marker;Annemarie A Donjacour;Rajvir Dahiya;Gerald R Cunha.
Developmental Biology (2003)
Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205.
Hiroshi Hirata;Yuji Hinoda;Varahram Shahryari;Guoren Deng.
Cancer Research (2015)
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
E. J. Noonan;R. F. Place;D. Pookot;S. Basak.
Oncogene (2009)
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1
S. W. Hayward;R. Dahiya;G. R. Cunha;J. Bartek.
In Vitro Cellular & Developmental Biology – Animal (1995)
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
Long-Cheng Li;Peter R. Carroll;Rajvir Dahiya.
Journal of the National Cancer Institute (2005)
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
Sharanjot Saini;Shahana Majid;Soichiro Yamamura;Z. Laura Tabatabai.
Clinical Cancer Research (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Francisco
Kagoshima University
Yamaguchi University
Kagoshima University
University of California, San Francisco
University of California, San Diego
University of California, San Francisco
University of California, San Francisco
NorthShore University HealthSystem
Chiba University
Max Planck Institute for Informatics
Huazhong University of Science and Technology
University of Naples Federico II
Johannes Gutenberg University of Mainz
University of Pennsylvania
Agricultural Research Service
University of North Carolina at Chapel Hill
Max Planck Society
Cranfield University
Newcastle University
University College London
Columbia University
University of South Australia
Sorbonne University
Griffith University
Brunel University London